BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 33453004)

  • 1. Late effects in survivors treated for lymphoma as adolescents and young adults: a population-based analysis.
    Lo AC; Chen B; Samuel V; Savage KJ; Freeman C; Goddard K
    J Cancer Surviv; 2021 Dec; 15(6):837-846. PubMed ID: 33453004
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Late mortality, secondary malignancy and hospitalisation in teenage and young adult survivors of Hodgkin lymphoma: report of the Childhood/Adolescent/Young Adult Cancer Survivors Research Program and the BC Cancer Agency Centre for Lymphoid Cancer.
    Bhuller KS; Zhang Y; Li D; Sehn LH; Goddard K; McBride ML; Rogers PC
    Br J Haematol; 2016 Mar; 172(5):757-68. PubMed ID: 26727959
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk of subsequent primary neoplasms in survivors of adolescent and young adult cancer (Teenage and Young Adult Cancer Survivor Study): a population-based, cohort study.
    Bright CJ; Reulen RC; Winter DL; Stark DP; McCabe MG; Edgar AB; Frobisher C; Hawkins MM
    Lancet Oncol; 2019 Apr; 20(4):531-545. PubMed ID: 30797674
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk of subsequent primary lymphoma in a cohort of 69,460 five-year survivors of childhood and adolescent cancer in Europe: The PanCareSurFup study.
    Dudley IM; Sunguc C; Heymer EJ; Winter DL; Teepen JC; Belle FN; Bárdi E; Bagnasco F; Gudmundsdottir T; Skinner R; Michel G; Byrne J; Øfstaas H; Jankovic M; Mazić MČ; Mader L; Loonen J; Garwicz S; Wiebe T; Alessi D; Allodji RS; Haddy N; Grabow D; Kaatsch P; Kaiser M; Maule MM; Jakab Z; Gunnes MW; Terenziani M; Zaletel LZ; Kuehni CE; Haupt R; de Vathaire F; Kremer LC; Lähteenmäki PM; Winther JF; Hjorth L; Hawkins MM; Reulen RC
    Cancer; 2023 Feb; 129(3):426-440. PubMed ID: 36444554
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Documentation and incidence of late effects and screening recommendations for adolescent and young adult head and neck cancer survivors treated with radiotherapy.
    Hamilton SN; Arshad O; Kwok J; Tran E; Fuchsia Howard A; Serrano I; Goddard K
    Support Care Cancer; 2019 Jul; 27(7):2609-2616. PubMed ID: 30467794
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk of Second Cancer in Hodgkin Lymphoma Survivors and Influence of Family History.
    Sud A; Thomsen H; Sundquist K; Houlston RS; Hemminki K
    J Clin Oncol; 2017 May; 35(14):1584-1590. PubMed ID: 28384078
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chronic medical conditions and late effects following non-Hodgkin lymphoma in HIV-uninfected and HIV-infected adolescents and young adults: a population-based study.
    Abrahão R; Li QW; Malogolowkin MH; Alvarez EM; Ribeiro RC; Wun T; Keegan THM
    Br J Haematol; 2020 Aug; 190(3):371-384. PubMed ID: 32080836
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adolescents and young adults with classical Hodgkin lymphoma in northern Tunisia: insights from an adult single-institutional study.
    Zawati I; Adouni O; Finetti P; Manai M; Manai M; Gamoudi A; Birnbaum D; Bertucci F; Mezlini A
    Cancer Radiother; 2020 Jun; 24(3):206-214. PubMed ID: 32171674
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased risk of second lung cancer in Hodgkin's lymphoma survivors: a meta-analysis.
    Ibrahim EM; Kazkaz GA; Abouelkhair KM; Al-Mansour MM; Al-Fayea TM; Al-Foheidi M; Bayer AM; Elmasri OA
    Lung; 2013 Feb; 191(1):117-34. PubMed ID: 23053567
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Patient-Reported Survivorship Care Practices and Late Effects After Treatment of Hodgkin and Non-Hodgkin Lymphoma.
    Frick MA; Vachani CC; Hampshire MK; Bach C; Arnold-Korzeniowski K; Metz JM; Hill-Kayser CE
    JCO Clin Cancer Inform; 2018 Dec; 2():1-10. PubMed ID: 30652594
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of the discussion of late effects and screening recommendations in survivors of adolescent and young adult (AYA) lymphoma.
    Lo AC; Samuel V; Chen B; Savage KJ; Freeman C; Goddard K
    J Cancer Surviv; 2021 Apr; 15(2):179-189. PubMed ID: 32767044
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Second malignant neoplasms in survivors of pediatric Hodgkin's lymphoma treated with low-dose radiation and chemotherapy.
    O'Brien MM; Donaldson SS; Balise RR; Whittemore AS; Link MP
    J Clin Oncol; 2010 Mar; 28(7):1232-9. PubMed ID: 20124178
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Late Cardiac Toxic Effects Associated With Treatment Protocols for Hodgkin Lymphoma in Children.
    Lo AC; Liu A; Liu Q; Yasui Y; Castellino SM; Kelly KM; Hererra AF; Friedberg JW; Friedman DL; Schwartz CL; Pei Q; Kessel S; Bergeron-Gravel S; Dama H; Roberts K; Constine LS; Hodgson DC
    JAMA Netw Open; 2024 Jan; 7(1):e2351062. PubMed ID: 38241048
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk of solid subsequent malignant neoplasms after childhood Hodgkin lymphoma-Identification of high-risk populations to guide surveillance: A report from the Late Effects Study Group.
    Holmqvist AS; Chen Y; Berano Teh J; Sun C; Birch JM; van den Bos C; Diller LR; Dilley K; Ginsberg J; Martin LT; Nagarajan R; Nathan PC; Neglia JP; Terenziani M; Tishler D; Meadows AT; Robison LL; Oberlin O; Bhatia S
    Cancer; 2019 Apr; 125(8):1373-1383. PubMed ID: 30556153
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Secondary Breast Cancer Risk by Radiation Volume in Women With Hodgkin Lymphoma.
    Conway JL; Connors JM; Tyldesley S; Savage KJ; Campbell BA; Zheng YY; Hamm J; Pickles T
    Int J Radiat Oncol Biol Phys; 2017 Jan; 97(1):35-41. PubMed ID: 27979454
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adult survivors of childhood malignant lymphoma are not aware of their risk of late effects.
    Hess SL; Jóhannsdóttir IM; Hamre H; Kiserud CE; Loge JH; Fosså SD
    Acta Oncol; 2011 Jun; 50(5):653-9. PubMed ID: 21261507
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Subsequent malignancies among long-term survivors of Hodgkin lymphoma and non-Hodgkin lymphoma: a pooled analysis of German cancer registry data (1990-2012).
    Baras N; Dahm S; Haberland J; Janz M; Emrich K; Kraywinkel K; Salama A
    Br J Haematol; 2017 Apr; 177(2):226-242. PubMed ID: 28106907
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term outcomes in Hodgkin lymphoma survivors. Temporary trends and comparison with general population.
    Núñez-García B; Clemente MB; Sánchez JC; Royuela A; Ibargüen BCS; Méndez M; López-Ibor JV; Martínez M; Traseira C; Garitaonaindia Y; Aguado R; Calvo V; Torrente M; Parejo C; Provencio Z; Provencio M
    Hematol Oncol; 2023 Aug; 41(3):407-414. PubMed ID: 36934306
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased risk of second malignant neoplasms in adolescents and young adults with cancer.
    Lee JS; DuBois SG; Coccia PF; Bleyer A; Olin RL; Goldsby RE
    Cancer; 2016 Jan; 122(1):116-23. PubMed ID: 26441212
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk of second breast cancer in female Hodgkin's lymphoma survivors: a meta-analysis.
    Ibrahim EM; Abouelkhair KM; Kazkaz GA; Elmasri OA; Al-Foheidi M
    BMC Cancer; 2012 May; 12():197. PubMed ID: 22639888
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.